ASX:AFPAft Pharmaceuticals Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Aft Pharmaceuticals Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlines AFT Pharmaceuticals Limited develops, licenses, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers approximately 130 prescription and non-prescription products for use in the areas of allergy, eye care, first aid, fungal, pain management, and skin care, as well as supplements. It is also involved in the distribution of pharmaceuticals. The company was founded in 1997 and is headquartered in Auckland, New Zealand.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Aft Pharmaceuticals. Previous Next 0.0 Community Rank Outperform VotesAft Pharmaceuticals has received 0 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAft Pharmaceuticals has received 0 “underperform” votes. (Add your “underperform” vote.)MarketBeat's community ratings are surveys of what our community members think about Aft Pharmaceuticals and other stocks. Vote “Outperform” if you believe AFP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AFP will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAft Pharmaceuticals does not currently pay a dividend.Dividend GrowthAft Pharmaceuticals does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aft Pharmaceuticals insiders have bought more of their company's stock than they have sold. Specifically, they have bought A$133,853.00 in company stock and sold A$0.00 in company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.60 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Drug Manufacturers—Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolASX:AFP Previous Symbol CUSIPN/A CIKN/A Webwww.aftpharm.com Phone64 9 488 0232Debt Debt-to-Equity Ratio273.55 Current Ratio2.20 Quick Ratio1.15Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive AFP News and Ratings via Email Sign-up to receive the latest news and ratings for AFP and its competitors with MarketBeat's FREE daily newsletter. Aft Pharmaceuticals (ASX:AFP) Frequently Asked Questions Has Aft Pharmaceuticals been receiving favorable news coverage? News articles about AFP stock have been trending negative recently, according to InfoTrie. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Aft Pharmaceuticals earned a media sentiment score of -2.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the company's share price in the near term. View the latest news about Aft Pharmaceuticals. Who are some of Aft Pharmaceuticals' key competitors? Some companies that are related to Aft Pharmaceuticals include AAC Technologies (ABSCF), Abattis Bioceuticals (ATT), AgraFlora Organics International (AGRA), AgraFlora Organics International (AGFAF), Avicanna (PDDPF), Benitec Biopharma (BLT), Biome Grow (BIOIF), Body and Mind (BAMM), Canopy Rivers (RIV), Chardan Healthcare Acquisition (PHGE), Chemesis International (CSI), Cresco Labs (VLNCF), Decibel Cannabis (DBCCF), Eisai (SGIOF) and Halo Labs (WSLFF). View all competitors. Who are Aft Pharmaceuticals' key executives? Aft Pharmaceuticals' management team includes the following people: Dr. Hartley Atkinson, Founder, CEO, MD & Exec. DirectorMs. Marree Atkinson, Chief of Staff & Exec. DirectorMr. Malcolm Tubby B.A., BA(Hon's), ICAEW, ICANZ, CFO & Company Sec.Mr. Murray Keith, Group Marketing Mang.Ms. Ioana Stanescu, Head of Drug Devel. What is Aft Pharmaceuticals' stock symbol? Aft Pharmaceuticals trades on the ASX under the ticker symbol "AFP." How big of a company is Aft Pharmaceuticals? Aft Pharmaceuticals has a market capitalization of $0.00. Aft Pharmaceuticals employs 86 workers across the globe. What is Aft Pharmaceuticals' official website? The official website for Aft Pharmaceuticals is www.aftpharm.com. How can I contact Aft Pharmaceuticals? The company can be reached via phone at 64 9 488 0232. This page was last updated on 7/5/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
